Neurotransmitters and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and Potential Therapeutic Targets
Gege Li(Zhejiang University), Ting Zhang(First Affiliated Hospital of Henan University of Science and Technology), Zengfeng Xin(Second Affiliated Hospital of Zhejiang University), Siyu Guo(Wuhan University), Fang Yuan(Qingdao University), Fangfang Li(Hangzhou Normal University), Yu Jiang(South China Agricultural University), Dang Wu(Second Affiliated Hospital of Zhejiang University), Jing Wang(Shanghai Jiao Tong University), Jianxia Cheng(The First People's Hospital of Changde), Yang Tang(Zhejiang Cancer Hospital), Zhihui Huang(Guangzhou University of Chinese Medicine), Yihan Yao(Zhejiang University), Bicheng Zhang(University of Electronic Science and Technology of China)
Cited by 4
Related Papers
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497
Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019
|Clinical Infectious Diseases|2020|458
Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models
|Scientific Reports|2019|260
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
|Frontiers in Immunology|2020|256